Skip to main content
SpringerLink
Log in

Safety and Quality Assessment of 175 Illegal Sexual Enhancement Products Seized in Red-Light Districts in Singapore

  • Short Communication
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

Background: In recent years, there has been increasing interest in the use of herbs and supplements as an alternative to drugs used for the treatment of erectile dysfunction, in order to enhance sexual performance. Over the years, adverse events associated with the consumption of natural health products for sexual enhancement and the treatment of erectile dysfunction have been reported.

Objective: The objective of this work was to assess the safety and quality of 175 sexual enhancement health products seized from makeshift stalls in red-light districts of Singapore.

Method: Seven raids were conducted by the Health Sciences Authority, Singapore, in two red-light districts in February and March 2008. 175 sexual enhancement health products seized from makeshift stalls were extracted with methanol and screened for Western drug adulterants using high performance liquid chromatography and gas chromatography-mass spectrometry. The labels and claims of the products were also evaluated.

Results: Of the 175 products evaluated, 134 (77%) were found to be adulterated with Western drugs or their analogues. Most of these 134 samples (123 [92%]) were found to be adulterated with sildenafil. The extent of adulteration of these illegal health products with Western drugs, including synthetic phosphodiesterase type 5 enzyme (PDE-5) inhibitors, and the risks of consuming such illegal sexual enhancement products are discussed in this study. Because of the scope of the raids, sildenafil was the most common adulterant found. In addition, some products were found to contain high contents of sildenafil (>100 mg) and high contents of the antidiabetic drug, glibenclamide (glyburide). The resultant severe hypoglycaemia has led to ten fatalities.

Conclusion: The presence of Western drug adulterants and their analogues in illegal sexual enhancement products seized from red-light districts in Singapore, and their often misleading labels and claims, put the health of consumers at risk. To safeguard public health, greater public awareness of the danger of consuming such illegal products and the lack of quality control of these illegal sexual enhancement health products is important.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Selvin E, Burnett AL, Plato EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med 2007; 120(2): 151–7

    Article  PubMed  Google Scholar 

  2. Sobel RE, Reynolds RF. Integrating evidence from multiple sources to evaluate post-approval safety: an example of sildenafil citrate and cardiovascular events. Curr Med Res Opin 2008; 24(7): 1861–8

    Article  PubMed  Google Scholar 

  3. Kontaras K, Varnavas V, Kyriakides ZS. Does sildenafil cause myocardial infarction or sudden cardiac death? Am J Cardiovasc Drugs 2008; 8(1): 1–7

    Article  PubMed  CAS  Google Scholar 

  4. Habek M, Petravic D. Stroke: an adverse reaction to sildenafil. Clin Neuropharmacol 2006; 29(3): 165–7

    Article  PubMed  CAS  Google Scholar 

  5. Milman HA, Amold SB. Neurologic, psychological and aggressive disturbances with sildenafil. Ann Pharmacother 2002; 36(7–8): 1129–34

    Article  PubMed  CAS  Google Scholar 

  6. Lloyd MJ, Fraunfelder FW. Drug-induced optic neuropathies. Drugs Today 2007; 43(11): 827–36

    Article  PubMed  CAS  Google Scholar 

  7. Wooltorton E. Visual loss with erectile dysfunction medications. Can Med Assoc J 2006 Aug; 175(4): 355

    Article  Google Scholar 

  8. Laties AM. Vision disorders and phosphodiesterase type 5 inhibitors: a review of the evidence to date. Drug Saf 2009; 32(1): 1–18

    Article  PubMed  CAS  Google Scholar 

  9. Nencini C, Barberi L, Runci FM, et al. Retinopathy induced by drugs and herbal medicines. Eur Rev Med Pharmacol Sci 2008; 12(5): 293–8

    PubMed  CAS  Google Scholar 

  10. Gorkin L, Hvidsten K, Sobel RE, et al. Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy. Int J Clin Pract 2006; 60(4): 500–3

    Article  PubMed  CAS  Google Scholar 

  11. Laties A, Sharlip I. Ocular safety in patients using sildenafil citrate therapy for erectile dysfunction. J Sex Med 2006; 3(1): 12–27

    Article  PubMed  CAS  Google Scholar 

  12. Philip A, Ramchandani S, Dorrance K, et al. Sildenafil-induced thrombocytopenia. Ann Intern Med 2008; 149(6): 437–49

    PubMed  Google Scholar 

  13. Blok-Tip L, Zomer B, Bakker F, et al. Structural elucidation of sildenafil analogues in herbal products. Food Addit Contam 2004; 21: 737–48

    Article  PubMed  CAS  Google Scholar 

  14. Bogusz MJ, Huda H, Al-Enazi E, et al. Application of LC-ESI-MS-MS for detection of synthetic adulterants in herbal remedies. J Pharm Biomed Anal 2006; 41(2): 554–64

    Article  PubMed  CAS  Google Scholar 

  15. Lam YH, Poon WT, Lai CK, et al. Identification of a novel vardenafil analogue in herbal product. J Pharm Biomed Anal 2007; 46(4): 804–7

    Article  PubMed  Google Scholar 

  16. Oh SS, Zou P, Low MY, et al. Detection of sildenafil analogues in herbal products for erectile dysfunction. J Toxicol Environ Health A 2006; 69: 1951–8

    Article  PubMed  CAS  Google Scholar 

  17. Shin MH, Hong MK, Kim WS, et al. Identification of a new analogue of sildenafil added illegally to a functional food for penile erectile dysfunction. Food Addit Contam 2003; 20: 793–6

    Article  PubMed  CAS  Google Scholar 

  18. Zou P, Hou PL, Low MY, et al. Structural elucidation of a tadalafil analogue found as an adulterant of a herbal product. Food Addit Contam 2006; 23(5): 446–51

    Article  PubMed  CAS  Google Scholar 

  19. Reepmeyer JC, Woodruff JT. Use of liquid chromatography-mass spectrometry and a hydrolytic technique for the detection and structure elucidation of a novel synthetic vardenafil designer drug added illegally to a “natural” herbal dietary supplement. J Chromatogr A 2006; 1125(1): 67–75

    Article  PubMed  CAS  Google Scholar 

  20. Zou P, Hou P, Oh SS, et al. Isolation and identification of thiohomosildenafil and thiosildenafil in health supplements. J Pharm Biomed Anal 2008; 47(2): 279–84

    Article  PubMed  CAS  Google Scholar 

  21. Hasegawa T, Takahashi K, Saijo M, et al. Isolation and structural elucidation of cyclopentynafil and N-octylnorta dalafil found in a dietary supplement. Chem Pharm Bull (Tokyo) 2009; 57(2): 185–9

    Article  CAS  Google Scholar 

  22. Health Sciences Authority of Singapore (HSA). HSA alerts on wider spread of harmful illegal health products [online]. Available from URL: http://www.hsa.gov.sg/publish/etc/medialib/hsa_library/corporate/pr20072009.Par.50960.File. tmp/PressRelease-HSAAlertsOnWiderSpreadOfHarmful IllegalHealthProducts-11Apr2008.pdf [Accessed 2008 May 20]

  23. Health Sciences Authority of Singapore (HSA). HSA updates on serious adverse reaction cases associated with harmful illegal health products [online]. Available from URL: http://www.hsa.gov.sg/publish/hsaportal/en/news_events/press_releases/2008.-hsaArticleBody-45903-Down loadFile.tmp/HSAPressRelease-HSAUpdatesOnSerious AdverseReactionCasesAssociatedWithHarmfulIllegal HealthProducts-25Apr2008.pdf [Accessed 2008 May 20]

  24. Health Sciences Authority of Singapore (HSA). HSA updates on fatalities & serious adverse reactions associated with the use of illegal health products [online]. Available from URL: http://www.hsa.gov.sg/publish/etc/medialib/hsa_library/corporate/pr20072009.Par.62900.File.tmp/MediaRelease-HSAUpdatesOnFatalities&ADRAssociated WithTheUseOfHarmfulIllegalHealthPdts-16May2008.pdf [Accessed 2008 May 20]

  25. Health Sciences Authority of Singapore (HSA). HSA updates on fatalities & serious adverse reactions associated with the use of illegal health products [online]. Available from URL: http://www.hsa.gov.sg/publish/etc/medialib/hsa_library/corporate/pr20072009.Par.16203.File.tmp/HSA PressRelease-HSAReiteratesConsumerAdvisoryMessages InSpiteDecreaseInSeriousAdverseReactionCasesAsssociated WithIllegalAphrodisiacProducts-31Oct2008.pdf [Accessed 2008 Nov 10]

  26. Kao SL, Chan CL, Tan B, et al. An unusual outbreak of hypoglycemia. N Engl J Med 2009; 360(7): 734–6

    Article  PubMed  CAS  Google Scholar 

  27. Liu SY, Woo SO, Koh HL. HPLC and GC-MS screening of Chinese proprietary medicine for undeclared therapeutic substances. J Pharm Biomed Anal 2001; 24(5–6): 983–92

    Article  PubMed  CAS  Google Scholar 

  28. Sweetman SC, editor. Martindale: the complete drug reference. 35th ed. London: Pharmaceutical Press, 2007

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Applied Sciences Group, Singapore

    Min-Yong Low, Yun Zeng, Xiao-Wei Ge & Bosco-Chen Bloodworth

  2. Department of Pharmacy, Faculty of Science, National University of Singapore, Science Drive 4, 117543, Singapore

    Min-Yong Low, Lin Li &  Hwee-Ling Koh

  3. Health Products Regulation Group, Enforcement Division, Health Sciences Authority, Singapore

    Ruth Lee

Authors
  1. Min-Yong Low
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yun Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lin Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiao-Wei Ge
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ruth Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Bosco-Chen Bloodworth
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hwee-Ling Koh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hwee-Ling Koh.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Cite this article

Low, MY., Zeng, Y., Li, L. et al. Safety and Quality Assessment of 175 Illegal Sexual Enhancement Products Seized in Red-Light Districts in Singapore. Drug-Safety 32, 1141–1146 (2009). https://doi.org/10.2165/11316690-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11316690-000000000-00000

Search

Navigation